Literature DB >> 16735378

The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients.

Cristianne Tomiyama1, Andrea Higa, Maria A Dalboni, Miguel Cendoroglo, Sergio A Draibe, Lilian Cuppari, Aluizio B Carvalho, Emilio M Neto, Maria Eugenia F Canziani.   

Abstract

BACKGROUND: Coronary heart disease (CHD) is the leading cause of death among end-stage renal disease patients. There is evidence that coronary calcification is a marker of atherosclerotic vascular disease and is predictive of cardiovascular events, especially in patients on renal replacement therapy. It has recently been suggested that CHD begins in the pre-dialysis period. However, data regarding coronary calcification in this population is scarce. This study was aimed at evaluating such coronary calcification and identifying related factors.
METHODS: A total of 96 chronic kidney disease out-patients who were not on dialysis were included. Patients presenting neoplastic, infectious or inflammatory diseases were excluded. Demographic characteristics, clinical profiles, laboratory test results and multislice computed tomography scans were evaluated.
RESULTS: The median age was 55 years (range 20-69 years), 67% were men and the median creatinine clearance was 37 ml/min/1.73 m(2). Coronary calcification, defined as a coronary artery calcification score (CACS) >0 Agatston units (AU), was seen in 61 patients (median 89.1 AU, range 0.37-2299.3 AU). On average, these patients were older, more often had diabetes, higher body mass indices and higher Framingham risk indices, as well as presenting higher proteinuria, intact parathyroid hormone (iPTH), blood glucose and triglyceride levels compared with those without calcification. Multiple logistic regression analysis, adjusted for age and diabetes, identified iPTH and triglyceride levels as independent determinants of calcification. Severe calcification (CACS >400 AU) was seen in 22 patients, who were also older and more frequently had a history of cardiovascular disease (CVD), as well as having higher levels of phosphorus, blood glucose and soluble Fas (sFas). Multiple logistic regression analysis, adjusted for age and diabetes, identified phosphorus and sFas levels as independent determinants of severe coronary calcification.
CONCLUSION: Coronary calcification is highly prevalent in pre-dialysis patients and correlates with traditional and non-traditional risk factors for CVD.

Entities:  

Mesh:

Year:  2006        PMID: 16735378     DOI: 10.1093/ndt/gfl291

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  39 in total

Review 1.  Chronic kidney disease and its complications.

Authors:  Robert Thomas; Abbas Kanso; John R Sedor
Journal:  Prim Care       Date:  2008-06       Impact factor: 2.907

2.  Relationship between abdominal aortic and coronary artery calcification as detected by computed tomography in chronic kidney disease patients.

Authors:  Yohei Takayama; Yoshinari Yasuda; Susumu Suzuki; Yohei Shibata; Yosuke Tatami; Kanako Shibata; Misao Niwa; Akihiro Sawai; Ryota Morimoto; Sawako Kato; Hideki Ishii; Shoichi Maruyama; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2015-07-12       Impact factor: 2.037

3.  Coronary artery calcification scores in patients with chronic kidney disease prior to dialysis: reliability as a trial outcome measure.

Authors:  Katherine A Barraclough; Lesley A Stevens; Lee Er; Debbie Rosenbaum; Jacqueline Brown; Pari Tiwari; Adeera Levin
Journal:  Nephrol Dial Transplant       Date:  2008-05-01       Impact factor: 5.992

4.  Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

Authors:  Rodrigo B Oliveira; Ana L E Cancela; Fabiana G Graciolli; Luciene M Dos Reis; Sérgio A Draibe; Lilian Cuppari; Aluizio B Carvalho; Vanda Jorgetti; Maria E Canziani; Rosa M A Moysés
Journal:  Clin J Am Soc Nephrol       Date:  2009-11-12       Impact factor: 8.237

5.  Impact of cardiovascular calcification in nondialyzed patients after 24 months of follow-up.

Authors:  Renato Watanabe; Marcelo M Lemos; Silvia R Manfredi; Sérgio A Draibe; Maria Eugênia F Canziani
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 8.237

6.  Outcomes associated with serum calcium level in men with non-dialysis-dependent chronic kidney disease.

Authors:  Csaba P Kovesdy; Olga Kuchmak; Jun L Lu; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

7.  Coronary calcification in patients with chronic kidney disease and coronary artery disease.

Authors:  Satoko Nakamura; Hatsue Ishibashi-Ueda; Sinichiro Niizuma; Fumiki Yoshihara; Takeshi Horio; Yuhei Kawano
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 8.237

8.  Generation of mouse conditional and null alleles of the type III sodium-dependent phosphate cotransporter PiT-1.

Authors:  Maria H Festing; Mei Y Speer; Hsueh-Ying Yang; Cecilia M Giachelli
Journal:  Genesis       Date:  2009-12       Impact factor: 2.487

9.  Low 25-hydroxyvitamin D levels and cognitive impairment in hemodialysis patients.

Authors:  Kamran Shaffi; Hocine Tighiouart; Tammy Scott; Kristina Lou; David Drew; Daniel Weiner; Mark Sarnak
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-28       Impact factor: 8.237

10.  Incidence and progression of coronary calcification in chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Bryan R Kestenbaum; Kathryn L Adeney; Ian H de Boer; Joachim H Ix; Michael G Shlipak; David S Siscovick
Journal:  Kidney Int       Date:  2009-08-19       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.